Smart Pill Technologies Market

Smart Pill Technologies Market


Smart Pill Technologies is the use of advanced methods for the preparation of prescription pills which has revolutionized patient monitoring, diagnosis of diseases and improved drug delivery. Smart pill technologies is the converging link between digital technology and healthcare industries. These smart pills have many benefits other than providing signals and alerts when consumed. By programming the pill accordingly, it can trigger a reminder according to the remainder time whenever the pill needs to be consumed. It can alert the physician, patient, medical staff or the caretaker when the medicine has been consumed which will help in accurate documentation of patient compliance or adherence. It can also provide alerts if the pill hasn't been consumed on a timely routine since multiple medications need to be taken by a large number of patients. Physicians do a good job of triangulating medications with their patients, since new additions/OTC medications are not routinely documented. So with the use of smart pill technology, the data collected can further be of assistance by identifying potential drug-drug interactions, errors in dosage, schedule errors and help identify/prevent adverse events. Pills can also turn to be useful in sending alert signals when medicines are past their expiry date.Patients on medications such as antibiotics can be monitored and alerted to complete their course to ensure that drug resistance is not encountered.

Smart Pill Technologies Market: Drivers and Restraints

The Smart pill technologies market is a flourishing market and has tremendous opportunities in future. The market has a wide scope in the monitoring and diagnosis of diseases. The rising prevalence of Gastro-intestinal diseases is acting as the major driver in the market. According to Centers for Disease Control and Prevention (CDC) 2015, it is currently estimated that about 1 –1.3 Mn people suffer from IBD in the United States. Prevalence of Crohn's disease is 201 per 100,000 adults and Ulcerative colitis is 238 per 100,000 adults. Also the changing lifestyle related syndromes and disorders will further boost this market. Likewise the increasing disposable income to avail the evolving innovative technologies in the market will further help in penetration of the developed as well as developing countries. The rising geriatric population will also act as a driver since this segment of population is more prone to IBD, Ulcerative colitis and Crohn's disease. The World Health Organization (WHO) has estimated that by 2050 world’s geriatric population count will reach around 2 Bn which will definitely contribute to the rapid growth of this market. The chronic therapy monitoring can help in curtailing health care costs as well. To illustrate: the smart pill technology combination of an ambulatory monitoring with anti-thrombolytic drug can reduce the number of physicians visits and ensure that anti-thrombolytic therapy is adjusted remotely while ensuring compliance. Even so, all technological advancements of this segment come with some caveats. Barriers to technology such as age, cost and utility, pose challenges which the manufacturers should attempt to overcome. While customizability is the feature of smart pill market, it can also prove to be a hindrance and can be very cumbersome since it would be difficult to manufacture according to individual consumer needs. Furthermore, adaptability is also a point of concern and these parameters can thus act as a restraint in the market.

Smart Pill Technologies Market: Segmentation

The Smart pill technologies market is classified on the basis of application, disease indication and geography.

Based on application, the global smart pill technologies market is segmented into the following:

Capsule Endoscopy

Small Bowel Video Capsule Endoscopy

Colon Capsule Endoscopy

OMOM Capsule Endoscopy Platform

Small Bowel Capsule Endoscopy

Controllable Capsule Endoscopy

Storable Capsule Endoscope

Colon Capsule Endoscope

pH Capsule Wireless Monitoring System

Impedance–pH Monitoring System

MiroCam

Upgraded MiroCam and Advanced Capsule Endoscope

The ANKON MCE System

CapsoCam

Drug Delivery

Patient monitoring of cancer

Based on disease indication, the global smart pill technologies market is segmented into the following:

Occult GI Bleeding

Crohn’s Disease

Small Bowel Tumors

Celiac Disease

Inherited Polyposis Syndromes

Smart Pill Technologies Market: Overview

The smart pill technologies has recently entered the market and is rapidly penetrating the developed as well as developing countries. The growing demand and escalating adoption rate for monitoring and treating diseases by newly advanced technologies has given an impetus to the global smart pill technologies market. In the last few years the market has seen high percentage of acceptance towards usage due to non-invasiveness, better patient accessibility and thorough monitoring. Capsule endoscopy accounted for the highest revenue in 2014. The first capsule endoscope model, which is now regarded as a first-line tool for the detection of abnormalities of the small bowel, was the PillCam SB. It was approved in Japan in April 2007. GI monitoring application segment is expected to register fastest growth in the forecast period, amongst all other segments. In the coming years, global smart pill technologies market will witness significant developments in innovation of a wide range of new products that will require novel marketing approaches. The smart pill technologies market is currently underpenetrated and in its nascent stage of development. Although the maximum revenues are generated by the developed countries, it is also observed that CAGR in the developing countries are high. The reason for the growth in the CAGR can be attributed to the increasing awareness in the latest innovative testing methods and the continuously improving economic conditions.

Smart Pill Technologies Market: Region-wise Outlook

On the basis of geography, Global Smart pill technologies market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America and Europe collectively accounted for the largest market share in the overall smart pills technology market, in 2014. North America accounted for about half the share of market revenue in 2014. The growth in this region is primarily attributed to the early adoption of novel technologies, a large patient population, high disposable incomes and the fresh marketing and commercializing of smart pill products. Asia Pacific is expected to grow at a remarkable CAGR for smart pills technologies market due to increasing healthcare awareness.

Smart Pill Technologies Market: Key Players

Key players in the global Nucleic Acid Testing market include CapsoVision, Inc., Given Imaging, Inc., Medimetrics S.A. de C.V., Olympus Corporation, and Bio-Images Research Limited, IntroMedic Inc., Chongqing Jinshan Science & Technology Group Co. Ltd., Proteus Digital Health Inc., Novartis AG, and Philips Healthcare.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Regional analysis includes

North America (U.S., Canada)

Latin America (Brazil, Mexico)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, BENELUX)

Eastern Europe (Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC, S. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint.

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.


1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Technology
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032
5.3.1. Patient Monitoring Technology
5.3.2. Drug Delivery Technology
5.3.3. Capsule Endoscopy Technology
5.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021
5.5. Absolute $ Opportunity Analysis By Technology, 2022-2032
Deep-dive segmentation will be available in the sample on request
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
6.3.1. Drug Delivery
6.3.2. Vital Sign Monitoring
6.3.3. Targeted Drug Delivery
6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
Deep-dive segmentation will be available in the sample on request
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Disease Indication
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Disease Indication, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Disease Indication, 2022-2032
7.3.1. Small Bowel Tumors
7.3.2. Occult GI Bleeding
7.3.3. Crohn’s Disease
7.3.4. Celiac Disease
7.3.5. Inherited Polyposis Syndromes
7.3.6. Others
7.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2017-2021
7.5. Absolute $ Opportunity Analysis By Disease Indication, 2022-2032
Deep-dive segmentation will be available in the sample on request
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Target Area
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By Target Area, 2017-2021
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Target Area, 2022-2032
8.3.1. Esophagus
8.3.2. Stomach
8.3.3. Small Intestine
8.3.4. Large Intestine
8.4. Y-o-Y Growth Trend Analysis By Target Area, 2017-2021
8.5. Absolute $ Opportunity Analysis By Target Area, 2022-2032
Deep-dive segmentation will be available in the sample on request
9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
9.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Academic & Research Institutes
9.3.4. Home Care Settings
9.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
9.5. Absolute $ Opportunity Analysis By End User, 2022-2032
Deep-dive segmentation will be available in the sample on request
10. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
10.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia & Pacific
10.3.6. MEA
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. U.K.
11.2.1.2. Canada
11.2.2. By Technology
11.2.3. By Application
11.2.4. By Disease Indication
11.2.5. By Target Area
11.2.6. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Technology
11.3.3. By Application
11.3.4. By Disease Indication
11.3.5. By Target Area
11.3.6. By End User
11.4. Key Takeaways
12. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Technology
12.2.3. By Application
12.2.4. By Disease Indication
12.2.5. By Target Area
12.2.6. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Technology
12.3.3. By Application
12.3.4. By Disease Indication
12.3.5. By Target Area
12.3.6. By End User
12.4. Key Takeaways
13. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. U.K.
13.2.1.3. France
13.2.1.4. Spain
13.2.1.5. Italy
13.2.1.6. Rest of Europe
13.2.2. By Technology
13.2.3. By Application
13.2.4. By Disease Indication
13.2.5. By Target Area
13.2.6. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Technology
13.3.3. By Application
13.3.4. By Disease Indication
13.3.5. By Target Area
13.3.6. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Technology
14.2.3. By Application
14.2.4. By Disease Indication
14.2.5. By Target Area
14.2.6. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Technology
14.3.3. By Application
14.3.4. By Disease Indication
14.3.5. By Target Area
14.3.6. By End User
14.4. Key Takeaways
15. South Asia & Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. India
15.2.1.2. Thailand
15.2.1.3. Indonesia
15.2.1.4. Malaysia
15.2.1.5. Singapore
15.2.1.6. Australia
15.2.1.7. New Zealand
15.2.1.8. Rest of South Asia & Pacific
15.2.2. By Technology
15.2.3. By Application
15.2.4. By Disease Indication
15.2.5. By Target Area
15.2.6. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Technology
15.3.3. By Application
15.3.4. By Disease Indication
15.3.5. By Target Area
15.3.6. By End User
15.4. Key Takeaways
16. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
16.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
16.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Technology
16.2.3. By Application
16.2.4. By Disease Indication
16.2.5. By Target Area
16.2.6. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Technology
16.3.3. By Application
16.3.4. By Disease Indication
16.3.5. By Target Area
16.3.6. By End User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. U.K.
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2021
17.1.2.1. By Technology
17.1.2.2. By Application
17.1.2.3. By Disease Indication
17.1.2.4. By Target Area
17.1.2.5. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2021
17.2.2.1. By Technology
17.2.2.2. By Application
17.2.2.3. By Disease Indication
17.2.2.4. By Target Area
17.2.2.5. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2021
17.3.2.1. By Technology
17.3.2.2. By Application
17.3.2.3. By Disease Indication
17.3.2.4. By Target Area
17.3.2.5. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2021
17.4.2.1. By Technology
17.4.2.2. By Application
17.4.2.3. By Disease Indication
17.4.2.4. By Target Area
17.4.2.5. By End User
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2021
17.5.2.1. By Technology
17.5.2.2. By Application
17.5.2.3. By Disease Indication
17.5.2.4. By Target Area
17.5.2.5. By End User
17.6. U.K.
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2021
17.6.2.1. By Technology
17.6.2.2. By Application
17.6.2.3. By Disease Indication
17.6.2.4. By Target Area
17.6.2.5. By End User
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2021
17.7.2.1. By Technology
17.7.2.2. By Application
17.7.2.3. By Disease Indication
17.7.2.4. By Target Area
17.7.2.5. By End User
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2021
17.8.2.1. By Technology
17.8.2.2. By Application
17.8.2.3. By Disease Indication
17.8.2.4. By Target Area
17.8.2.5. By End User
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2021
17.9.2.1. By Technology
17.9.2.2. By Application
17.9.2.3. By Disease Indication
17.9.2.4. By Target Area
17.9.2.5. By End User
17.10. China
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2021
17.10.2.1. By Technology
17.10.2.2. By Application
17.10.2.3. By Disease Indication
17.10.2.4. By Target Area
17.10.2.5. By End User
17.11. Japan
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2021
17.11.2.1. By Technology
17.11.2.2. By Application
17.11.2.3. By Disease Indication
17.11.2.4. By Target Area
17.11.2.5. By End User
17.12. South Korea
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2021
17.12.2.1. By Technology
17.12.2.2. By Application
17.12.2.3. By Disease Indication
17.12.2.4. By Target Area
17.12.2.5. By End User
17.13. India
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2021
17.13.2.1. By Technology
17.13.2.2. By Application
17.13.2.3. By Disease Indication
17.13.2.4. By Target Area
17.13.2.5. By End User
17.14. Thailand
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2021
17.14.2.1. By Technology
17.14.2.2. By Application
17.14.2.3. By Disease Indication
17.14.2.4. By Target Area
17.14.2.5. By End User
17.15. Indonesia
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2021
17.15.2.1. By Technology
17.15.2.2. By Application
17.15.2.3. By Disease Indication
17.15.2.4. By Target Area
17.15.2.5. By End User
17.16. Malaysia
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2021
17.16.2.1. By Technology
17.16.2.2. By Application
17.16.2.3. By Disease Indication
17.16.2.4. By Target Area
17.16.2.5. By End User
17.17. Singapore
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2021
17.17.2.1. By Technology
17.17.2.2. By Application
17.17.2.3. By Disease Indication
17.17.2.4. By Target Area
17.17.2.5. By End User
17.18. Australia
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2021
17.18.2.1. By Technology
17.18.2.2. By Application
17.18.2.3. By Disease Indication
17.18.2.4. By Target Area
17.18.2.5. By End User
17.19. New Zealand
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2021
17.19.2.1. By Technology
17.19.2.2. By Application
17.19.2.3. By Disease Indication
17.19.2.4. By Target Area
17.19.2.5. By End User
17.20. GCC Countries
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2021
17.20.2.1. By Technology
17.20.2.2. By Application
17.20.2.3. By Disease Indication
17.20.2.4. By Target Area
17.20.2.5. By End User
17.21. South Africa
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2021
17.21.2.1. By Technology
17.21.2.2. By Application
17.21.2.3. By Disease Indication
17.21.2.4. By Target Area
17.21.2.5. By End User
17.22. Israel
17.22.1. Pricing Analysis
17.22.2. Market Share Analysis, 2021
17.22.2.1. By Technology
17.22.2.2. By Application
17.22.2.3. By Disease Indication
17.22.2.4. By Target Area
17.22.2.5. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Technology
18.3.3. By Application
18.3.4. By Disease Indication
18.3.5. By Target Area
18.3.6. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Boston Scientific Corporation
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. GE Healthcare
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Microchips
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Novartis AG
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. Olympus Medical Technology
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Phillips
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Otsuka America Pharmaceutical, Inc
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. Yooma Wellness Inc.
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. Medtronic Private Limited
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. CapsoVision, Inc.
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings